PHARMACEUTICAL & BIOTECH DISTRIBUTION SUPPORT
Archbow's Effective Distribution Strategies Get Products To Patients as Efficiently as Possible
-
Advising on Optimal Product Distribution Channel(s)
-
Comprehensive RFP Management and Channel Partner Selection
-
State Licensure
-
3PL (Traditional vs Title)
-
Wholesaler/Specialty Distribution
-
Retail/Mail Order/Subscription/Alternative Distribution Solutions
-
Specialty Pharmacy
-
Group Purchasing Organization
-
Hospital, IDN, IDN Network Administrator, and 340b guidance
-
VA/FSS/DoD Strategies
-
-
Contracting Guidance, DSA review and benchmarking
-
Distribution Program Implementation Oversight and Assistance
-
Comprehensive Financial Modeling
-
Ongoing Vendor Performance Analysis
-
Generic and Biosimilar Conversion and LOE Market Share Loss Prevention
-
US and Global Early Access Program Distribution Strategy
-
Compendia Listing
Product Distribution
PRODUCT DISTRIBUTION DIFFERENTIATORS
Archbow’s distribution practice is led by a team of former VP-level executives at Accredo, AmerisourceBergen, CuraScript, and McKesson. Our team members have:
Reviewed and analyzed hundreds of contracts for SP, wholesaler, 3PL, and SD
Overseen operational implementation plans at the industry’s leading SD
Established the business development functions of a 3PL business unit and a CGT business unit
Developed the Distribution Strategy for multiple product launches
Archbow is an active member in the Healthcare Distribution Alliance, maintaining deep connections to all stakeholders in the pharmaceutical distribution space.
Download How Healthy are Your Market Access Programs? A Guide to Performing Check-Ups on Pharmaceutical Distribution and Patient Access Programs here